Sandoz's pegfilgrastim biosimilar gains FDA approval

04:44 EST 7 Nov 2019 | SmartBrief

The FDA approved the biosimilar Ziextenzo, or pegfilgrastim-bmez, made by Sandoz, to reduce incidence of infection manifested -More

Original Article: Sandoz's pegfilgrastim biosimilar gains FDA approval


More From BioPortfolio on "Sandoz's pegfilgrastim biosimilar gains FDA approval"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...